Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.61 extracted from

  • Yoh, T.; Hatano, E.; Kasai, Y.; Fuji, H.; Nishi, K.; Toriguchi, K.; Sueoka, H.; Ohno, M.; Seo, S.; Iwaisako, K.; Taura, K.; Yamaguchi, R.; Kurokawa, M.; Fujimoto, J.; Kimura, T.; Uemoto, S.; Nishi, E.
    Serum nardilysin, a surrogate marker for epithelial-mesenchymal transition, predicts prognosis of intrahepatic cholangiocarcinoma after surgical resection (2019), Clin. Cancer Res., 25, 619-628 .
    View publication on PubMed

Application

Application Comment Organism
medicine serum nardilysin has potential as a novel prognostic biomarker for intrahepatic cholangiocarcinoma, which may reflect epithelial-mesenchymal transition features in primary tumor regions. It is proposed that the preoperative evaluation of serum nardilysin is a potential clinical tool for predicting tumor recurrence in and the overall prognosis of patients after curative-intent surgery Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens O43847 patients with intrahepatic cholangiocarcinoma
-

Synonyms

Synonyms Comment Organism
NRDc
-
Homo sapiens